1,554
Participants
Start Date
May 31, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Alogliptin
Alogliptin tablets.
Alogliptin placebo
Alogliptin placebo-matching tablets.
Pioglitazone
Pioglitazone tablets.
Pioglitazone placebo
Pioglitazone placebo-matching tablets.
Birmingham
Columbiana
Huntsville
Phoenix
Little Rock
Searcy
Sherwood
Burbank
Foothill Ranch
Irvine
Sacramento
San Diego
Temecula
Tustin
Colorado Springs
Washington D.C.
Hollywood
Kissimmee
Miami
New Port Richey
Pembroke Pines
Pinellas Park
Sarasota
Vero Beach
Atlanta
Roswell
Savannah
Warner Robins
Chicago
Peoria
Lafayette
South Bend
Waterloo
Munfordville
Baton Rouge
Marrero
Elkridge
Prince Frederick
Towson
Marlborough
Ann Arbor
Cadillac
Detroit
Livonia
Kansas City
North Las Vegas
Blackwood
Trenton
New York
Charlotte
Statesville
Gallipolis
Marion
Clinton
Oklahoma City
Tulsa
Allentown
Altoona
Philadelphia
Pittsburgh
Alcoa
Milan
Morristown
Arlington
Carrollton
Dallas
Fort Worth
Houston
San Antonio
Temple
Salt Lake City
Burlington
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Multiple Cities
Lead Sponsor
Takeda
INDUSTRY